Science News
from research organizations

Maternal diabetes impairs methylation of imprinted gene in oocytes

Date:
March 20, 2013
Source:
Society for the Study of Reproduction
Summary:
For the first time, researchers have shown that poorly controlled maternal diabetes has an adverse effect on methylation of the maternal imprinting gene Peg3, contributing to impaired development in offspring.
Share:
       
FULL STORY

For the first time, researchers have shown that poorly controlled maternal diabetes has an adverse effect on methylation of the maternal imprinting gene Peg3, contributing to impaired development in offspring.

Previous studies have revealed that offspring of diabetic mothers display a higher incidence of malformations and fetal death, even when a one-cell embryo is transplanted from a diabetic to a non-diabetic mother. Diabetic mothers' oocytes tend to exhibit reduced glucose metabolism, compromised communication between cumulus cells and oocytes, mitochondrial malfunction, and a decreased ovulation rate, all of which can be traced back to reduced gene expression in the embryos.

Qing-Yuan Sun and Zhao-Jia Ge of the Chinese Academy of Sciences hypothesized that the reduced gene expression results from disturbed DNA re-methylation during oogenesis and oocyte maturation. The team bred and examined three different mouse populations: one with spontaneously occurring diabetes, one with diabetes induced by STZ injection, and one without diabetes. After mating on Day 15, the diabetic mice presented with reduced pregnancy rates (approx. 74% vs. 100% in non-diabetic mice) and increased embryo death rates (approx. 16% vs. 0%), consistent with previous reports.

Focusing on the methylation patterns of one paternally methylated gene (H19) and two maternally methylated genes (Peg3 and Snrpn), the team found that none showed impaired methylation until 35 days after STZ injection; however, embryo development and number of offspring were already affected on Day 15. On Day 35, methylation of Peg3 was significantly decreased, with an unmethylated oocyte rate nearly 22% higher in both types of diabetic mice compared to controls. H19 remained unaffected and effects on Snrpn were not significant.

As for the female offspring of diabetic mothers, their oocytes did not appear to have any methylation abnormalities; however, due to the difficulty of producing offspring conceived after Day 15, it will be extremely difficult to determine whether those females are similarly unaffected.


Story Source:

The above story is based on materials provided by Society for the Study of Reproduction. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ge ZJ, Liang XW, Guo L, Liang QX, Luo SM, Wang YP, Wei YC, Han ZM, Schatten H, Suna QY. Maternal diabetes causes alterations of DNA methylation statuses of some imprinted genes in murine oocytes. Biol Reprod, 20 March 2013; (in press) DOI: 10.1095/biolreprod.112.105981

Cite This Page:

Society for the Study of Reproduction. "Maternal diabetes impairs methylation of imprinted gene in oocytes." ScienceDaily. ScienceDaily, 20 March 2013. <www.sciencedaily.com/releases/2013/03/130320155226.htm>.
Society for the Study of Reproduction. (2013, March 20). Maternal diabetes impairs methylation of imprinted gene in oocytes. ScienceDaily. Retrieved May 24, 2015 from www.sciencedaily.com/releases/2013/03/130320155226.htm
Society for the Study of Reproduction. "Maternal diabetes impairs methylation of imprinted gene in oocytes." ScienceDaily. www.sciencedaily.com/releases/2013/03/130320155226.htm (accessed May 24, 2015).

Share This Page: